{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:13:50Z","timestamp":1788387230066,"version":"build-2803163510"},"reference-count":115,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.eprac.2024.12.018","type":"journal-article","created":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:43:24Z","timestamp":1735346604000},"page":"511-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Challenge of Fractures in Patients With Chronic Kidney Disease"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-9876","authenticated-orcid":false,"given":"Andrea G.","family":"Kattah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia M.","family":"Titan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wermers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib3","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1681\/ASN.2006050546","article-title":"Association of kidney function with incident hip fracture in older adults","volume":"18","author":"Fried","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.018_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.kint.2018.09.022","article-title":"The Fracture Risk Assessment Tool (FRAX(R)) predicts fracture risk in patients with chronic kidney disease","volume":"95","author":"Whitlock","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MNH.0000000000000418","article-title":"Time to rethink the use of bone biopsy to prevent fractures in patients with chronic kidney disease","volume":"27","author":"Steller Wagner Martins","year":"2018","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.eprac.2024.12.018_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.archger.2019.05.015","article-title":"The prevalence and impact of falls in elderly dialysis patients: frail elderly Patient Outcomes on Dialysis (FEPOD) study","volume":"83","author":"van Loon","year":"2019","journal-title":"Arch Gerontol Geriatr"},{"issue":"10","key":"10.1016\/j.eprac.2024.12.018_bib8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/jbmr.2862","article-title":"Hip fracture in patients with non-dialysis-requiring chronic kidney disease","volume":"31","author":"Kim","year":"2016","journal-title":"J\u00a0Bone Miner Res"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib9","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1056\/NEJM199108223250804","article-title":"Rapid loss of vertebral mineral density after renal transplantation","volume":"325","author":"Julian","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jbmr\/zjae021","article-title":"Risk factors for hip and vertebral fractures in chronic kidney disease: the CRIC study","volume":"39","author":"Hsu","year":"2024","journal-title":"J\u00a0Bone Miner Res"},{"issue":"23","key":"10.1016\/j.eprac.2024.12.018_bib11","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.018_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00002142-200210000-00002","article-title":"Bone microstructure in osteoporosis: transilial biopsy and histomorphometry","volume":"13","author":"Barger-Lux","year":"2002","journal-title":"Top Magn Reson Imag"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.018_bib13","first-page":"785","article-title":"NIH consensus development panel on osteoporosis prevention D, therapy. Osteoporosis prevention, diagnosis, and therapy","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.eprac.2024.12.018_bib14","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.eprac.2024.12.018_bib15","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/ndt\/gfh876","article-title":"Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone","volume":"20","author":"Iwasaki-Ishizuka","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1525-139X.2009.00595.x","article-title":"Effects of uremic toxins on vascular and bone remodeling","volume":"22","author":"Barreto","year":"2009","journal-title":"Semin Dial"},{"issue":"11","key":"10.1016\/j.eprac.2024.12.018_bib17","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1016\/j.eprac.2024.12.018_bib18","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2215\/CJN.04301206","article-title":"Histomorphometric measurements of bone turnover, mineralization, and volume","volume":"3","author":"Ott","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00774-018-0902-7","article-title":"Comparison of clinical, biochemical and histomorphometric analysis of bone biopsies in dialysis patients with and without fractures","volume":"37","author":"Santos","year":"2019","journal-title":"J\u00a0Bone Miner Metabol"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.018_bib20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/j.ajkd.2019.07.022","article-title":"Longitudinal evolution of markers of mineral metabolism in patients with CKD: the chronic renal insufficiency cohort (CRIC) study","volume":"75","author":"Isakova","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.018_bib21","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/sdi.12415","article-title":"Sclerostin, osteocytes, and chronic kidney disease - mineral bone disorder","volume":"28","author":"Moyses","year":"2015","journal-title":"Semin Dial"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.eprac.2024.12.018_bib23","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.1981.03310340020020","article-title":"Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis","volume":"245","author":"Vincenti","year":"1981","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.eprac.2024.12.018_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrneph.2013.111","article-title":"Phosphate and FGF-23 in ageing and disturbed mineral metabolism","volume":"9","author":"Klotho","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MNH.0000000000000992","article-title":"Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease","volume":"33","author":"Evenepoel","year":"2024","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.eprac.2024.12.018_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1177829","article-title":"Pathophysiology of bone disease in\u00a0chronic kidney disease: from basics to renal osteodystrophy and osteoporosis","volume":"14","author":"Aguilar","year":"2023","journal-title":"Front Physiol"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.018_bib28","doi-asserted-by":"crossref","first-page":"c256","DOI":"10.1159\/000317207","article-title":"Moderate chronic kidney disease in women is associated with fracture occurrence independently of osteoporosis","volume":"116","author":"Kinsella","year":"2010","journal-title":"Nephron Clin Pract"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib29","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2215\/CJN.09130912","article-title":"Estimated GFR and fracture risk: a population-based study","volume":"8","author":"Elliott","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.018_bib30","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"issue":"9","key":"10.1016\/j.eprac.2024.12.018_bib31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/jbmr.4636","article-title":"Evaluation of renal osteodystrophy and serum bone-related biomarkers in a peritoneal dialysis population","volume":"37","author":"Pereira","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.018_bib32","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ekir.2022.02.022","article-title":"Low turnover renal osteodystrophy with abnormal bone quality and vascular calcification in patients with mild-to-moderate CKD","volume":"7","author":"El-Husseini","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.018_bib33","first-page":"289","article-title":"Association between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients","volume":"36","author":"Barreto","year":"2014","journal-title":"J\u00a0Bras Nefrol"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.018_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.afos.2019.05.001","article-title":"Diabetes and bone","volume":"5","author":"Hygum","year":"2019","journal-title":"Osteoporos Sarcopenia"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib36","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jbm4.10067","article-title":"Fracture risk in dialysis and kidney transplanted patients: a systematic review","volume":"3","author":"Sidibe","year":"2019","journal-title":"JBMR Plus"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib38","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/jbmr.1630","article-title":"Repression of osteocyte Wnt\/beta-catenin signaling is an early event in the progression of renal osteodystrophy","volume":"27","author":"Sabbagh","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.018_bib39","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH","volume":"40","author":"Jilka","year":"2007","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.eprac.2024.12.018_bib40","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/ckj\/sfab081","article-title":"Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4","volume":"14","author":"Neto","year":"2021","journal-title":"Clin Kidney J"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","article-title":"Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease","volume":"90","author":"Carrillo-Lopez","year":"2016","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.018_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000180501","article-title":"Effect of correction of metabolic acidosis on bone mineralisation rates in patients with renal osteomalacia","volume":"15","author":"Cochran","year":"1975","journal-title":"Nephron"},{"key":"10.1016\/j.eprac.2024.12.018_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000381000","article-title":"A\u00a0practical approach to vitamin D deficiency and rickets","volume":"28","author":"Allgrove","year":"2015","journal-title":"Endocr Dev"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.018_bib45","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11914-017-0364-1","article-title":"Renal osteodystrophy or kidney-induced osteoporosis?","volume":"15","author":"Moe","year":"2017","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MNH.0000000000000798","article-title":"Clinical utility of bone turnover markers in patients with chronic kidney disease","volume":"31","author":"Smout","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib47","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.018_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/endrev\/bnac031","article-title":"Bone turnover markers: basic biology to clinical applications","volume":"44","author":"Schini","year":"2023","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.018_bib49","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1681\/ASN.2017050584","article-title":"Diagnostic accuracy of biomarkers and imaging for bone turnover in renal osteodystrophy","volume":"29","author":"Salam","year":"2018","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.018_bib50","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy","volume":"79","author":"Jorgensen","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.eprac.2024.12.018_bib51","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib52","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.018_bib53","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s00198-019-04864-4","article-title":"Chronic kidney disease is associated with low BMD at the hip but not at the spine","volume":"30","author":"Bezerra de Carvalho","year":"2019","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.eprac.2024.12.018_bib54","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.00720116","article-title":"Trabecular bone score and incident fragility fracture risk in adults with reduced kidney function","volume":"11","author":"Naylor","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jocd.2007.12.010","article-title":"Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions","volume":"11","author":"Engelke","year":"2008","journal-title":"J\u00a0Clin Densitom"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.018_bib56","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00198-017-3956-9","article-title":"Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities","volume":"28","author":"Marques","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.eprac.2024.12.018_bib57","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"113","year":"2009","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"10.1016\/j.eprac.2024.12.018_bib58","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/M16-2752","article-title":"Benefits and harms of osteoporosis medications in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"166","author":"Wilson","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib59","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2215\/CJN.03410321","article-title":"Bone and mineral disease in kidney transplant recipients","volume":"17","author":"Khairallah","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.eprac.2024.12.018_bib60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD--the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10611","article-title":"Vitamin D analogues and fracture risk in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials","volume":"6","author":"Khelifi","year":"2022","journal-title":"JBMR plus"},{"issue":"Suppl 1","key":"10.1016\/j.eprac.2024.12.018_bib63","first-page":"S38","article-title":"Impact of cinacalcet hydrochloride on bone histology in patients with secondary hyperparathyroidism","volume":"12","author":"Yajima","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"11","key":"10.1016\/j.eprac.2024.12.018_bib64","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.2215\/CJN.0000000000000254","article-title":"Changes in bone quality after treatment with etelcalcetide","volume":"18","author":"Khairallah","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.018_bib65","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1681\/ASN.2014040414","article-title":"Effects of cinacalcet on fracture events in patients receiving hemodialysis: the EVOLVE trial","volume":"26","author":"Moe","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.018_bib66","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/ijcp.12532","article-title":"Estimated glomerular filtration rate leads to higher drug dose recommendations in the elderly compared with creatinine clearance","volume":"69","author":"Hudson","year":"2015","journal-title":"Int J Clin Pract"},{"issue":"4S","key":"10.1016\/j.eprac.2024.12.018_bib67","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.eprac.2024.12.018_bib68","article-title":"Performance of\u00a0creatinine and cystatin-based equations on estimating measured Glomerular Filtration Rate in hematological and solid cancers","author":"Titan SML","year":"2024","journal-title":"CJASN"},{"key":"10.1016\/j.eprac.2024.12.018_bib69","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bone.2013.10.024","article-title":"Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients","volume":"59","author":"Jobke","year":"2014","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib70","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","article-title":"Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability","volume":"49","author":"Bellido","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.eprac.2024.12.018_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115751","article-title":"Is there a role for bisphosphonates in vascular calcification in chronic kidney disease?","volume":"142","author":"Hildebrand","year":"2021","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11657-020-0702-2","article-title":"Bisphosphonate utilization across the spectrum of eGFR","volume":"15","author":"Titan","year":"2020","journal-title":"Arch Osteoporosis"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.018_bib73","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jbmr.4235","article-title":"Safety of oral bisphosphonates in\u00a0moderate-to-severe chronic kidney disease: a binational cohort analysis","volume":"36","author":"Robinson","year":"2021","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.018_bib74","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2165\/00002018-199614030-00003","article-title":"Adverse effects of bisphosphonates. A comparative review","volume":"14","author":"Adami","year":"1996","journal-title":"Drug Saf"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.018_bib75","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.bone.2011.09.035","article-title":"Effects of intravenous ibandronate injection on renal function in women with postmenopausal osteoporosis at high risk for renal disease--the DIVINE study","volume":"49","author":"Miller","year":"2011","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.018_bib76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/MNH.0000000000000585","article-title":"Bisphosphonate therapy in CKD: the current state of affairs","volume":"29","author":"Damasiewicz","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib77","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J\u00a0Bone Miner Res"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib78","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1440-1797.2005.00436.x","article-title":"Effects of short-term alendronate on bone mineral density in haemodialysis patients","volume":"10","author":"Wetmore","year":"2005","journal-title":"Nephrology"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib79","first-page":"510","article-title":"Treatment of reduced bone density with ibandronate in dialysis patients","volume":"21","author":"Bergner","year":"2008","journal-title":"J\u00a0Nephrol"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.018_bib80","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jbmr.3676","article-title":"Effects of denosumab and alendronate on bone health and vascular function in hemodialysis patients: a randomized, controlled trial","volume":"34","author":"Iseri","year":"2019","journal-title":"J\u00a0Bone Miner Res"},{"issue":"9","key":"10.1016\/j.eprac.2024.12.018_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238248","article-title":"Effectiveness of antiresorptive medications in women on long-term dialysis after hip fracture: a population-based cohort study","volume":"15","author":"Lin","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.018_bib82","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/j.ajkd.2021.06.031","article-title":"Diagnosis and management of osteoporosis in advanced kidney disease: a review","volume":"79","author":"Ginsberg","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"10.1016\/j.eprac.2024.12.018_bib83","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1007\/s00198-021-05975-7","article-title":"Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism","volume":"32","author":"Evenepoel","year":"2021","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib84","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.eprac.2024.12.018_bib85","article-title":"Severe hypocalcemia with denosumab among older female dialysis-dependent patients","author":"Bird","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.eprac.2024.12.018_bib86","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bone.2019.07.007","article-title":"Skeletal levels of bisphosphonate in the setting of chronic kidney disease are independent of remodeling rate and lower with fractionated dosing","volume":"127","author":"Swallow","year":"2019","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib87","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11657-021-00971-0","article-title":"Denosumab in chronic kidney disease: a narrative review of treatment efficacy and safety","volume":"16","author":"Gopaul","year":"2021","journal-title":"Arch Osteoporosis"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib88","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"issue":"9","key":"10.1016\/j.eprac.2024.12.018_bib89","first-page":"1195","article-title":"Long-term effect of denosumab on bone disease in patients with CKD","volume":"18","author":"Iseri","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib90","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/s41598-020-59143-8","article-title":"Denosumab for dialysis patients with osteoporosis: a cohort study","volume":"10","author":"Kunizawa","year":"2020","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.eprac.2024.12.018_bib91","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1210\/jc.2014-1154","article-title":"An open-label, prospective pilot clinical study of denosumab for severe hyperparathyroidism in patients with low bone mass undergoing dialysis","volume":"99","author":"Chen","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2024.12.018_bib92","article-title":"Efficacy of osteoporosis medications for patients with chronic kidney disease: an updated systematic review and network meta-analysis","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib93","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1210\/jc.2010-1502","article-title":"Effects of denosumab treatment and discontinuation on bone mineral density and bone turnover markers in postmenopausal women with low bone mass","volume":"96","author":"Bone","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2024.12.018_bib94","doi-asserted-by":"crossref","first-page":"e4155","DOI":"10.1210\/clinem\/dgab321","article-title":"The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation","volume":"106","author":"Makras","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib95","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00198-018-4533-6","article-title":"Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies","volume":"29","author":"Thongprayoon","year":"2018","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib98","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s00198-020-05391-3","article-title":"Impact of denosumab on cardiovascular calcification in patients with secondary hyperparathyroidism undergoing dialysis: a pilot study","volume":"31","author":"Chen","year":"2020","journal-title":"Osteoporos Int"},{"issue":"18","key":"10.1016\/j.eprac.2024.12.018_bib99","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2165\/0003495-200868180-00012","article-title":"Teriparatide: a review of its use in osteoporosis","volume":"68","author":"Blick","year":"2008","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.eprac.2024.12.018_bib100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nrneph.2013.182","article-title":"Therapy for patients with CKD and low bone mineral density","volume":"9","author":"Ott","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"10.1016\/j.eprac.2024.12.018_bib101","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/j.ajkd.2015.01.025","article-title":"Teriparatide and bone turnover and formation in a hemodialysis patient with low-turnover bone disease: a case report","volume":"65","author":"Palcu","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.018_bib102","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000316708","article-title":"Treatment of hemodialysis-associated adynamic bone disease with teriparatide (PTH1-34): a pilot study","volume":"33","author":"Cejka","year":"2010","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib103","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int"},{"issue":"12","key":"10.1016\/j.eprac.2024.12.018_bib104","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1080\/03007995.2019.1656955","article-title":"Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial","volume":"35","author":"Bilezikian","year":"2019","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.018_bib105","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00198-021-06139-3","article-title":"Teriparatide-associated calciphylaxis: a case series","volume":"33","author":"Kim","year":"2022","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.eprac.2024.12.018_bib106","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11657-019-0672-4","article-title":"No impact of anti-Rank ligand and PTH analogs on cardiovascular risk in postmenopausal osteoporosis: a systematic literature review and meta-analysis","volume":"15","author":"Ferrieres","year":"2020","journal-title":"Arch Osteoporosis"},{"issue":"16","key":"10.1016\/j.eprac.2024.12.018_bib107","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.eprac.2024.12.018_bib108","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.018_bib109","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5414\/CN111111","article-title":"FGF-23 and sclerostin in serum and bone of CKD patients","volume":"99","author":"Lima","year":"2023","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.eprac.2024.12.018_bib110","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.kint.2019.06.007","article-title":"Comparison of serum levels with bone content and gene expression indicate a contradictory effect of kidney transplantation on sclerostin","volume":"96","author":"Araujo","year":"2019","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib111","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/jbmr.4563","article-title":"Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease","volume":"37","author":"Miller","year":"2022","journal-title":"J\u00a0Bone Miner Res"},{"issue":"3","key":"10.1016\/j.eprac.2024.12.018_bib112","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/ndt\/gfy129","article-title":"Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it","volume":"34","author":"Brandenburg","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib113","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2013.02.366","article-title":"Bone alkaline phosphatase in CKD-mineral bone disorder","volume":"62","author":"Sardiwal","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.eprac.2024.12.018_bib114","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2013.07.016","article-title":"Aminoterminal propeptide of type I procollagen (PINP) in chronic kidney disease patients: the assay matters","volume":"425","author":"Cavalier","year":"2013","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.1016\/j.eprac.2024.12.018_bib115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00223-008-9127-4","article-title":"Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients","volume":"82","author":"Shidara","year":"2008","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.eprac.2024.12.018_bib116","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","article-title":"Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction","volume":"69","author":"Yamada","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"8","key":"10.1016\/j.eprac.2024.12.018_bib117","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","author":"Nickolas","year":"2013","journal-title":"J\u00a0Bone Miner Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24008784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24008784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:42:22Z","timestamp":1744717342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24008784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1530891X24008784"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.12.018","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Challenge of Fractures in Patients With Chronic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}